ByHeart
New York, NY · Healthcare, Health Care, Manufacturing · 201 employees
ByHeart is an infant nutrition company built from the ground up to deliver real innovation on behalf of babies and parents. Our mission is simple: make the best formula in the world. That’s why we studied the latest breast milk science, worked directly with suppliers we know and trust, set uncompromising quality standards, developed our own small batch blending process, built our own manufacturing
Funding history
- Funding Round — $95.5M — May 2026
- Funding Round — $72.2M — Mar 2026
- Funding Round — $95.5M — May 2025
- Funding Round — $72.2M — Mar 2025
- Funding Round — $95.5M — Apr 2024
Recent signals
- May 07, 2026: Raised $95.5M
- Mar 31, 2026: Raised $72.2M
- May 13, 2025: Raised $95.5M
- Mar 27, 2025: Raised $72.2M
- Oct 17, 2024: Launched ByHeart Expands Its Next-Generation Baby Formula to Walmart, Whole Foods Market, and Wegmans, Increasing Retail Presence Over 200%
- Apr 08, 2024: Raised $95.5M
- Jan 25, 2023: Acquired Byheart Acquires Additional Domestic Infant Formula Manufacturing Facility Tripling Its Supply Capacity And Continuing To Fortify Formula Production In The U.S.
- Jan 13, 2023: Raised $29.6M
See plans & pricing → Track ByHeart’s funding, hiring, and signals — with verified contacts — on Fundz.